Synthesis, calf thymus DNA binding, in-vitro cytotoxicity, molecular docking, and antimicrobial studies of novel metal complexes containing a 2,3-diaminopyridine derivative Schiff base
M A Helal, Rasha M S Shoaib, A Z El-Sonbati, M A Diab, M A El-Mogazy, M M El-Zahed, Sh M Morgan · 2026
Read Synthesis, calf thymus DNA binding, in-vitro cytotoxicity, molecular docking, and antimicrobial studies of novel metal complexes containing a 2,3-diaminopyridine derivative Schiff base by M A Helal, Rasha M S Shoaib, A Z El-Sonbati, M A Diab, M A El-Mogazy, M M El-Zahed, Sh M Morgan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13216323.txt.
Description
M. A. Helal and co-authors present a 2026 chemistry study of a new Schiff base ligand and the metal complexes built from it, tested as possible anticancer and antimicrobial agents. Schiff bases grip metal ions at several points, which makes them versatile drug scaffolds.
The ligand, assembled from a pyridine building block and a benzene-diol partner, was combined with copper, cobalt, manganese, nickel, and palladium ions. Spectral evidence showed it binding through two oxygen and two nitrogen atoms, with most complexes taking octahedral shapes and the palladium one square planar. The compounds inhibited the tested fungi more strongly than the bacteria. Cell tests against the MCF-7 breast cancer line showed notable antitumour activity, and docking simulations suggested plausible fits to cancer-related protein targets.
Catalog record
| CREATOR | M A Helal, Rasha M S Shoaib, A Z El-Sonbati, M A Diab, M A El-Mogazy, M M El-Zahed, Sh M Morgan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 84 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |